Results 81 to 90 of about 5,177,357 (230)

Primary Sclerosing Cholangitis Associated with Severe Ulcerative Colitis in a Young Woman: Case Report

open access: yesJournal of Ardabil University of Medical Sciences, 2019
Background: Primary sclerosing cholangitis is a rare and progressive cholestatic disease characterized by narrowing of the biliary tract. Despite high levels of ulcerative colitis, early diagnosis of primary sclerosing cholangitis before the diagnosis of
Somaieh Matin   +2 more
doaj  

The management of primary sclerosing cholangitis.

open access: yes, 1998
Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by a progressive, obliterating fibrosis of the intrahepatic and extrahepatic bile ducts.
Stephen A. Mitchell, Roger W.G. Chapman
core   +1 more source

Primary sclerosing cholangitis: diagnostic and management challenges

open access: yes, 2017
Sanjeev Sirpal,1 Natasha Chandok2 1Department of Medicine, Centre Hospitalier de l’Université de Montréal (CHUM), University of Montreal, Montreal, QC, 2Department of Medicine, University of Western Ontario, London, ON, Canada ...
Sirpal S, Chandok N
core  

Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
This review systematically summarizes a full spectrum of non‐invasive diagnostic approaches for portal hypertension (PH), including imaging modalities, elastography, serum biomarkers, composite scoring systems and endoscopic ultrasound‐guided portal pressure gradient (EUS‐PPG), and analyzes their performance across different liver disease etiologies ...
Lijia Yin, Huikuan Chu, Ling Yang
wiley   +1 more source

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.

open access: yes, 1986
The aetiology of primary sclerosing cholangitis is unknown, but it is closely associated with ulcerative colitis. Serum anticolon antibodies, crossreacting with portal tracts, have been reported in patients with ulcerative colitis but no studies have ...
W S Selby   +5 more
core   +1 more source

Primary Sclerosing Cholangitis Multiple Phenotypes, Multiple Approaches [PDF]

open access: yes, 2016
Primary sclerosing cholangitis (PSC) is a heterogeneous, idiopathic, inflammatory disorder frequently associated with inflammatory bowel diseases. PSC patients may be classified into several subphenotypes.
Sarkar, Souvik, Bowlus, Christopher L
core   +1 more source

Impact of Single Viable Hepatocellular Carcinoma ≤ 3 cm on Survival After Liver Transplantation

open access: yesANZ Journal of Surgery, EarlyView.
An Australian multi‐centre cohort study shows significantly lower 5‐year HCC‐specific mortality for those with no viable disease compared to those with a single viable tumour ≤ 3 cm, on imaging prior to transplantation. A lower AFP level and complete response on mRECIST criteria also reduced risk.
Lauren C. Y. Tang   +12 more
wiley   +1 more source

Sclerosing cholangitis.

open access: yes, 1995
PURPOSE OF REVIEW: Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by strictures of the biliary tree. It is immune mediated, although the precise cause remains unknown. Recent reports have shown a higher prevalence and
Chapman, Roger   +10 more
core   +1 more source

Economic Evaluation of Prolonged Hypothermic Oxygenated Machine Perfusion Enabling Daytime Liver Transplantation

open access: yesArtificial Organs, EarlyView.
DHOPE‐PRO enabled daytime liver transplantation with comparable one‐year transplantation‐related costs versus short‐duration DHOPE. Higher perfusion costs were offset by lower surgery‐related costs, suggesting DHOPE‐PRO can improve scheduling logistics without increasing overall hospital costs.
Linda C. Woltjes   +47 more
wiley   +1 more source

Corticosteroid Exposure in Autoimmune Hepatitis: Early Toxicity, Cumulative Burden and Associations With Long‐Term Patient‐Reported Outcomes

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In a patient‐reported cohort of 565 adults with autoimmune hepatitis, 96.6% reported corticosteroid‐related side effects within 6 months and long‐term toxicity increased with cumulative exposure. The findings support earlier tapering, toxicity monitoring, lower induction dosing when appropriate and selective budesonide use in carefully chosen non ...
Elizabeth Gentry   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy